nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Topotecan—lung cancer	0.036	0.142	CbGbCtD
Fulvestrant—CYP3A4—Gefitinib—lung cancer	0.0329	0.13	CbGbCtD
Fulvestrant—CYP3A4—Teniposide—lung cancer	0.0319	0.126	CbGbCtD
Fulvestrant—CYP3A4—Vinorelbine—lung cancer	0.0253	0.1	CbGbCtD
Fulvestrant—CYP3A4—Crizotinib—lung cancer	0.0202	0.0796	CbGbCtD
Fulvestrant—CYP3A4—Erlotinib—lung cancer	0.0194	0.0768	CbGbCtD
Fulvestrant—CYP3A4—Paclitaxel—lung cancer	0.0178	0.0703	CbGbCtD
Fulvestrant—CYP3A4—Irinotecan—lung cancer	0.0176	0.0694	CbGbCtD
Fulvestrant—CYP3A4—Vinblastine—lung cancer	0.0156	0.0617	CbGbCtD
Fulvestrant—CYP3A4—Etoposide—lung cancer	0.0141	0.0556	CbGbCtD
Fulvestrant—CYP3A4—Docetaxel—lung cancer	0.0129	0.0508	CbGbCtD
Fulvestrant—EPHX2—mammary gland—lung cancer	0.0107	0.14	CbGeAlD
Fulvestrant—CYP3A4—Doxorubicin—lung cancer	0.00959	0.0379	CbGbCtD
Fulvestrant—ESRRA—respiratory system—lung cancer	0.00625	0.0818	CbGeAlD
Fulvestrant—ESR2—mammary gland—lung cancer	0.00563	0.0737	CbGeAlD
Fulvestrant—ESRRA—bronchus—lung cancer	0.00514	0.0673	CbGeAlD
Fulvestrant—ESRRA—trachea—lung cancer	0.00462	0.0605	CbGeAlD
Fulvestrant—ESRRA—cardiac atrium—lung cancer	0.00434	0.0568	CbGeAlD
Fulvestrant—ESR1—mammary gland—lung cancer	0.00386	0.0505	CbGeAlD
Fulvestrant—EPHX2—lung—lung cancer	0.00379	0.0496	CbGeAlD
Fulvestrant—ESR2—respiratory system—lung cancer	0.00375	0.0491	CbGeAlD
Fulvestrant—ESRRA—bone marrow—lung cancer	0.00366	0.0479	CbGeAlD
Fulvestrant—ESRRA—lung—lung cancer	0.00332	0.0434	CbGeAlD
Fulvestrant—ESR2—epithelium—lung cancer	0.00314	0.041	CbGeAlD
Fulvestrant—NR1H4—lymph node—lung cancer	0.00297	0.0388	CbGeAlD
Fulvestrant—EPHX2—lymph node—lung cancer	0.00259	0.0339	CbGeAlD
Fulvestrant—ESR1—respiratory system—lung cancer	0.00257	0.0336	CbGeAlD
Fulvestrant—Estradiol—UGT1A1—lung cancer	0.00234	0.403	CrCbGaD
Fulvestrant—ESRRA—lymph node—lung cancer	0.00227	0.0297	CbGeAlD
Fulvestrant—ESR1—epithelium—lung cancer	0.00215	0.0281	CbGeAlD
Fulvestrant—ESR2—lung—lung cancer	0.00199	0.0261	CbGeAlD
Fulvestrant—ESR1—lung—lung cancer	0.00136	0.0179	CbGeAlD
Fulvestrant—ESR2—lymph node—lung cancer	0.00136	0.0178	CbGeAlD
Fulvestrant—Estradiol—ABCG2—lung cancer	0.00132	0.227	CrCbGaD
Fulvestrant—Estradiol—CYP1A1—lung cancer	0.00103	0.177	CrCbGaD
Fulvestrant—ESR1—lymph node—lung cancer	0.000933	0.0122	CbGeAlD
Fulvestrant—Estradiol—ALB—lung cancer	0.000574	0.0988	CrCbGaD
Fulvestrant—Estradiol—ABCB1—lung cancer	0.000548	0.0943	CrCbGaD
Fulvestrant—Pain—Irinotecan—lung cancer	0.000327	0.000872	CcSEcCtD
Fulvestrant—Constipation—Irinotecan—lung cancer	0.000327	0.000872	CcSEcCtD
Fulvestrant—Arthralgia—Paclitaxel—lung cancer	0.000326	0.000867	CcSEcCtD
Fulvestrant—Chest pain—Paclitaxel—lung cancer	0.000326	0.000867	CcSEcCtD
Fulvestrant—Myalgia—Paclitaxel—lung cancer	0.000326	0.000867	CcSEcCtD
Fulvestrant—Anxiety—Paclitaxel—lung cancer	0.000325	0.000864	CcSEcCtD
Fulvestrant—Malnutrition—Docetaxel—lung cancer	0.000324	0.000864	CcSEcCtD
Fulvestrant—Decreased appetite—Gemcitabine—lung cancer	0.000324	0.000863	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000323	0.000861	CcSEcCtD
Fulvestrant—Nausea—Topotecan—lung cancer	0.000322	0.000858	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000322	0.000857	CcSEcCtD
Fulvestrant—Fatigue—Gemcitabine—lung cancer	0.000321	0.000856	CcSEcCtD
Fulvestrant—Constipation—Gemcitabine—lung cancer	0.000319	0.000849	CcSEcCtD
Fulvestrant—Pain—Gemcitabine—lung cancer	0.000319	0.000849	CcSEcCtD
Fulvestrant—Nausea—Erlotinib—lung cancer	0.000319	0.000849	CcSEcCtD
Fulvestrant—Diarrhoea—Vinorelbine—lung cancer	0.000318	0.000846	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000317	0.000843	CcSEcCtD
Fulvestrant—Infection—Etoposide—lung cancer	0.000316	0.000843	CcSEcCtD
Fulvestrant—Back pain—Docetaxel—lung cancer	0.000314	0.000835	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Irinotecan—lung cancer	0.000313	0.000834	CcSEcCtD
Fulvestrant—Paraesthesia—Cisplatin—lung cancer	0.000312	0.000831	CcSEcCtD
Fulvestrant—Infection—Paclitaxel—lung cancer	0.00031	0.000826	CcSEcCtD
Fulvestrant—Dyspnoea—Cisplatin—lung cancer	0.00031	0.000825	CcSEcCtD
Fulvestrant—Skin disorder—Etoposide—lung cancer	0.000309	0.000824	CcSEcCtD
Fulvestrant—Hyperhidrosis—Etoposide—lung cancer	0.000308	0.00082	CcSEcCtD
Fulvestrant—Dizziness—Vinorelbine—lung cancer	0.000307	0.000818	CcSEcCtD
Fulvestrant—Nervous system disorder—Paclitaxel—lung cancer	0.000306	0.000815	CcSEcCtD
Fulvestrant—Breast disorder—Doxorubicin—lung cancer	0.000304	0.000809	CcSEcCtD
Fulvestrant—Anorexia—Etoposide—lung cancer	0.000303	0.000808	CcSEcCtD
Fulvestrant—Skin disorder—Paclitaxel—lung cancer	0.000303	0.000808	CcSEcCtD
Fulvestrant—Abdominal pain—Irinotecan—lung cancer	0.000303	0.000806	CcSEcCtD
Fulvestrant—Body temperature increased—Irinotecan—lung cancer	0.000303	0.000806	CcSEcCtD
Fulvestrant—Decreased appetite—Cisplatin—lung cancer	0.000302	0.000805	CcSEcCtD
Fulvestrant—Hyperhidrosis—Paclitaxel—lung cancer	0.000302	0.000804	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Cisplatin—lung cancer	0.0003	0.000799	CcSEcCtD
Fulvestrant—Anaemia—Docetaxel—lung cancer	0.0003	0.000798	CcSEcCtD
Fulvestrant—Infestation—Methotrexate—lung cancer	0.000299	0.000796	CcSEcCtD
Fulvestrant—Infestation NOS—Methotrexate—lung cancer	0.000299	0.000796	CcSEcCtD
Fulvestrant—Depression—Methotrexate—lung cancer	0.000298	0.000794	CcSEcCtD
Fulvestrant—Anorexia—Paclitaxel—lung cancer	0.000298	0.000793	CcSEcCtD
Fulvestrant—Pain—Cisplatin—lung cancer	0.000297	0.000792	CcSEcCtD
Fulvestrant—Vomiting—Vinorelbine—lung cancer	0.000295	0.000786	CcSEcCtD
Fulvestrant—Body temperature increased—Gemcitabine—lung cancer	0.000295	0.000785	CcSEcCtD
Fulvestrant—Rash—Vinorelbine—lung cancer	0.000293	0.000779	CcSEcCtD
Fulvestrant—Dermatitis—Vinorelbine—lung cancer	0.000292	0.000779	CcSEcCtD
Fulvestrant—Headache—Vinorelbine—lung cancer	0.000291	0.000774	CcSEcCtD
Fulvestrant—Influenza—Doxorubicin—lung cancer	0.00029	0.000774	CcSEcCtD
Fulvestrant—Leukopenia—Docetaxel—lung cancer	0.00029	0.000773	CcSEcCtD
Fulvestrant—Sweating—Methotrexate—lung cancer	0.000287	0.000764	CcSEcCtD
Fulvestrant—Paraesthesia—Etoposide—lung cancer	0.000286	0.000762	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000284	0.000758	CcSEcCtD
Fulvestrant—Dyspnoea—Etoposide—lung cancer	0.000284	0.000756	CcSEcCtD
Fulvestrant—Cough—Docetaxel—lung cancer	0.000283	0.000754	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Methotrexate—lung cancer	0.000283	0.000753	CcSEcCtD
Fulvestrant—Insomnia—Paclitaxel—lung cancer	0.000282	0.000752	CcSEcCtD
Fulvestrant—Hypersensitivity—Irinotecan—lung cancer	0.000282	0.000751	CcSEcCtD
Fulvestrant—Paraesthesia—Paclitaxel—lung cancer	0.00028	0.000747	CcSEcCtD
Fulvestrant—Dyspnoea—Paclitaxel—lung cancer	0.000278	0.000741	CcSEcCtD
Fulvestrant—Decreased appetite—Etoposide—lung cancer	0.000277	0.000737	CcSEcCtD
Fulvestrant—Myalgia—Docetaxel—lung cancer	0.000276	0.000735	CcSEcCtD
Fulvestrant—Chest pain—Docetaxel—lung cancer	0.000276	0.000735	CcSEcCtD
Fulvestrant—Arthralgia—Docetaxel—lung cancer	0.000276	0.000735	CcSEcCtD
Fulvestrant—Nausea—Vinorelbine—lung cancer	0.000276	0.000734	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Etoposide—lung cancer	0.000275	0.000732	CcSEcCtD
Fulvestrant—Dyspepsia—Paclitaxel—lung cancer	0.000275	0.000732	CcSEcCtD
Fulvestrant—Body temperature increased—Cisplatin—lung cancer	0.000275	0.000732	CcSEcCtD
Fulvestrant—Asthenia—Irinotecan—lung cancer	0.000275	0.000732	CcSEcCtD
Fulvestrant—Fatigue—Etoposide—lung cancer	0.000275	0.000731	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000274	0.00073	CcSEcCtD
Fulvestrant—Constipation—Etoposide—lung cancer	0.000272	0.000725	CcSEcCtD
Fulvestrant—Pain—Etoposide—lung cancer	0.000272	0.000725	CcSEcCtD
Fulvestrant—Decreased appetite—Paclitaxel—lung cancer	0.000271	0.000723	CcSEcCtD
Fulvestrant—Haemoglobin—Methotrexate—lung cancer	0.00027	0.000719	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00027	0.000718	CcSEcCtD
Fulvestrant—Fatigue—Paclitaxel—lung cancer	0.000269	0.000717	CcSEcCtD
Fulvestrant—Haemorrhage—Methotrexate—lung cancer	0.000268	0.000715	CcSEcCtD
Fulvestrant—Hepatitis—Methotrexate—lung cancer	0.000268	0.000715	CcSEcCtD
Fulvestrant—Asthenia—Gemcitabine—lung cancer	0.000268	0.000713	CcSEcCtD
Fulvestrant—Constipation—Paclitaxel—lung cancer	0.000267	0.000711	CcSEcCtD
Fulvestrant—Pain—Paclitaxel—lung cancer	0.000267	0.000711	CcSEcCtD
Fulvestrant—Pharyngitis—Methotrexate—lung cancer	0.000266	0.00071	CcSEcCtD
Fulvestrant—Pruritus—Gemcitabine—lung cancer	0.000264	0.000703	CcSEcCtD
Fulvestrant—Infection—Docetaxel—lung cancer	0.000263	0.0007	CcSEcCtD
Fulvestrant—Diarrhoea—Irinotecan—lung cancer	0.000262	0.000698	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Etoposide—lung cancer	0.00026	0.000693	CcSEcCtD
Fulvestrant—Nervous system disorder—Docetaxel—lung cancer	0.000259	0.000691	CcSEcCtD
Fulvestrant—Infestation NOS—Doxorubicin—lung cancer	0.000259	0.00069	CcSEcCtD
Fulvestrant—Infestation—Doxorubicin—lung cancer	0.000259	0.00069	CcSEcCtD
Fulvestrant—Skin disorder—Docetaxel—lung cancer	0.000257	0.000685	CcSEcCtD
Fulvestrant—Hypersensitivity—Cisplatin—lung cancer	0.000256	0.000682	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Paclitaxel—lung cancer	0.000255	0.00068	CcSEcCtD
Fulvestrant—Diarrhoea—Gemcitabine—lung cancer	0.000255	0.00068	CcSEcCtD
Fulvestrant—Dizziness—Irinotecan—lung cancer	0.000253	0.000674	CcSEcCtD
Fulvestrant—Urticaria—Etoposide—lung cancer	0.000253	0.000674	CcSEcCtD
Fulvestrant—Anorexia—Docetaxel—lung cancer	0.000252	0.000672	CcSEcCtD
Fulvestrant—Abdominal pain—Etoposide—lung cancer	0.000252	0.00067	CcSEcCtD
Fulvestrant—Body temperature increased—Etoposide—lung cancer	0.000252	0.00067	CcSEcCtD
Fulvestrant—Urinary tract infection—Doxorubicin—lung cancer	0.000252	0.00067	CcSEcCtD
Fulvestrant—Asthenia—Cisplatin—lung cancer	0.000249	0.000664	CcSEcCtD
Fulvestrant—Sweating—Doxorubicin—lung cancer	0.000248	0.000661	CcSEcCtD
Fulvestrant—Urticaria—Paclitaxel—lung cancer	0.000248	0.000661	CcSEcCtD
Fulvestrant—Abdominal pain—Paclitaxel—lung cancer	0.000247	0.000657	CcSEcCtD
Fulvestrant—Body temperature increased—Paclitaxel—lung cancer	0.000247	0.000657	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Doxorubicin—lung cancer	0.000245	0.000652	CcSEcCtD
Fulvestrant—Angiopathy—Methotrexate—lung cancer	0.000244	0.000649	CcSEcCtD
Fulvestrant—Vomiting—Irinotecan—lung cancer	0.000243	0.000648	CcSEcCtD
Fulvestrant—Immune system disorder—Methotrexate—lung cancer	0.000242	0.000646	CcSEcCtD
Fulvestrant—Rash—Irinotecan—lung cancer	0.000241	0.000643	CcSEcCtD
Fulvestrant—Dermatitis—Irinotecan—lung cancer	0.000241	0.000642	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000241	0.000642	CcSEcCtD
Fulvestrant—Headache—Irinotecan—lung cancer	0.00024	0.000639	CcSEcCtD
Fulvestrant—Insomnia—Docetaxel—lung cancer	0.000239	0.000637	CcSEcCtD
Fulvestrant—Diarrhoea—Cisplatin—lung cancer	0.000238	0.000633	CcSEcCtD
Fulvestrant—Paraesthesia—Docetaxel—lung cancer	0.000238	0.000633	CcSEcCtD
Fulvestrant—Vomiting—Gemcitabine—lung cancer	0.000237	0.000631	CcSEcCtD
Fulvestrant—Dyspnoea—Docetaxel—lung cancer	0.000236	0.000628	CcSEcCtD
Fulvestrant—Rash—Gemcitabine—lung cancer	0.000235	0.000626	CcSEcCtD
Fulvestrant—Dermatitis—Gemcitabine—lung cancer	0.000235	0.000626	CcSEcCtD
Fulvestrant—Hypersensitivity—Etoposide—lung cancer	0.000235	0.000625	CcSEcCtD
Fulvestrant—Malnutrition—Methotrexate—lung cancer	0.000234	0.000622	CcSEcCtD
Fulvestrant—Haemoglobin—Doxorubicin—lung cancer	0.000234	0.000622	CcSEcCtD
Fulvestrant—Headache—Gemcitabine—lung cancer	0.000234	0.000622	CcSEcCtD
Fulvestrant—Dyspepsia—Docetaxel—lung cancer	0.000233	0.00062	CcSEcCtD
Fulvestrant—Hepatitis—Doxorubicin—lung cancer	0.000232	0.000619	CcSEcCtD
Fulvestrant—Haemorrhage—Doxorubicin—lung cancer	0.000232	0.000619	CcSEcCtD
Fulvestrant—Pharyngitis—Doxorubicin—lung cancer	0.000231	0.000614	CcSEcCtD
Fulvestrant—Decreased appetite—Docetaxel—lung cancer	0.00023	0.000613	CcSEcCtD
Fulvestrant—Hypersensitivity—Paclitaxel—lung cancer	0.00023	0.000613	CcSEcCtD
Fulvestrant—Oedema peripheral—Doxorubicin—lung cancer	0.000229	0.00061	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Docetaxel—lung cancer	0.000228	0.000608	CcSEcCtD
Fulvestrant—Asthenia—Etoposide—lung cancer	0.000228	0.000608	CcSEcCtD
Fulvestrant—Connective tissue disorder—Doxorubicin—lung cancer	0.000228	0.000608	CcSEcCtD
Fulvestrant—Fatigue—Docetaxel—lung cancer	0.000228	0.000608	CcSEcCtD
Fulvestrant—Nausea—Irinotecan—lung cancer	0.000227	0.000606	CcSEcCtD
Fulvestrant—Pain—Docetaxel—lung cancer	0.000226	0.000603	CcSEcCtD
Fulvestrant—Constipation—Docetaxel—lung cancer	0.000226	0.000603	CcSEcCtD
Fulvestrant—Back pain—Methotrexate—lung cancer	0.000226	0.000602	CcSEcCtD
Fulvestrant—Pruritus—Etoposide—lung cancer	0.000225	0.0006	CcSEcCtD
Fulvestrant—Asthenia—Paclitaxel—lung cancer	0.000224	0.000597	CcSEcCtD
Fulvestrant—Nausea—Gemcitabine—lung cancer	0.000221	0.00059	CcSEcCtD
Fulvestrant—Vomiting—Cisplatin—lung cancer	0.000221	0.000589	CcSEcCtD
Fulvestrant—Pruritus—Paclitaxel—lung cancer	0.000221	0.000588	CcSEcCtD
Fulvestrant—Rash—Cisplatin—lung cancer	0.000219	0.000584	CcSEcCtD
Fulvestrant—Dermatitis—Cisplatin—lung cancer	0.000219	0.000583	CcSEcCtD
Fulvestrant—Diarrhoea—Etoposide—lung cancer	0.000218	0.00058	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Docetaxel—lung cancer	0.000216	0.000576	CcSEcCtD
Fulvestrant—Anaemia—Methotrexate—lung cancer	0.000216	0.000575	CcSEcCtD
Fulvestrant—Diarrhoea—Paclitaxel—lung cancer	0.000214	0.000569	CcSEcCtD
Fulvestrant—Angiopathy—Doxorubicin—lung cancer	0.000211	0.000562	CcSEcCtD
Fulvestrant—Dizziness—Etoposide—lung cancer	0.000211	0.000561	CcSEcCtD
Fulvestrant—Immune system disorder—Doxorubicin—lung cancer	0.00021	0.000559	CcSEcCtD
Fulvestrant—Vertigo—Methotrexate—lung cancer	0.00021	0.000559	CcSEcCtD
Fulvestrant—Abdominal pain—Docetaxel—lung cancer	0.000209	0.000557	CcSEcCtD
Fulvestrant—Body temperature increased—Docetaxel—lung cancer	0.000209	0.000557	CcSEcCtD
Fulvestrant—Leukopenia—Methotrexate—lung cancer	0.000209	0.000557	CcSEcCtD
Fulvestrant—Dizziness—Paclitaxel—lung cancer	0.000206	0.00055	CcSEcCtD
Fulvestrant—Nausea—Cisplatin—lung cancer	0.000206	0.00055	CcSEcCtD
Fulvestrant—Cough—Methotrexate—lung cancer	0.000204	0.000543	CcSEcCtD
Fulvestrant—Vomiting—Etoposide—lung cancer	0.000202	0.000539	CcSEcCtD
Fulvestrant—Malnutrition—Doxorubicin—lung cancer	0.000202	0.000539	CcSEcCtD
Fulvestrant—Rash—Etoposide—lung cancer	0.000201	0.000535	CcSEcCtD
Fulvestrant—Dermatitis—Etoposide—lung cancer	0.000201	0.000534	CcSEcCtD
Fulvestrant—Headache—Etoposide—lung cancer	0.000199	0.000531	CcSEcCtD
Fulvestrant—Chest pain—Methotrexate—lung cancer	0.000199	0.00053	CcSEcCtD
Fulvestrant—Myalgia—Methotrexate—lung cancer	0.000199	0.00053	CcSEcCtD
Fulvestrant—Arthralgia—Methotrexate—lung cancer	0.000199	0.00053	CcSEcCtD
Fulvestrant—Vomiting—Paclitaxel—lung cancer	0.000198	0.000529	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000198	0.000526	CcSEcCtD
Fulvestrant—Rash—Paclitaxel—lung cancer	0.000197	0.000524	CcSEcCtD
Fulvestrant—Dermatitis—Paclitaxel—lung cancer	0.000197	0.000524	CcSEcCtD
Fulvestrant—Back pain—Doxorubicin—lung cancer	0.000196	0.000521	CcSEcCtD
Fulvestrant—Headache—Paclitaxel—lung cancer	0.000196	0.000521	CcSEcCtD
Fulvestrant—Hypersensitivity—Docetaxel—lung cancer	0.000195	0.000519	CcSEcCtD
Fulvestrant—Asthenia—Docetaxel—lung cancer	0.00019	0.000506	CcSEcCtD
Fulvestrant—Infection—Methotrexate—lung cancer	0.000189	0.000505	CcSEcCtD
Fulvestrant—Nausea—Etoposide—lung cancer	0.000189	0.000504	CcSEcCtD
Fulvestrant—Pruritus—Docetaxel—lung cancer	0.000187	0.000499	CcSEcCtD
Fulvestrant—Nervous system disorder—Methotrexate—lung cancer	0.000187	0.000498	CcSEcCtD
Fulvestrant—Anaemia—Doxorubicin—lung cancer	0.000187	0.000498	CcSEcCtD
Fulvestrant—Nausea—Paclitaxel—lung cancer	0.000185	0.000494	CcSEcCtD
Fulvestrant—Skin disorder—Methotrexate—lung cancer	0.000185	0.000493	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methotrexate—lung cancer	0.000184	0.000491	CcSEcCtD
Fulvestrant—Vertigo—Doxorubicin—lung cancer	0.000182	0.000484	CcSEcCtD
Fulvestrant—Anorexia—Methotrexate—lung cancer	0.000182	0.000484	CcSEcCtD
Fulvestrant—Leukopenia—Doxorubicin—lung cancer	0.000181	0.000482	CcSEcCtD
Fulvestrant—Diarrhoea—Docetaxel—lung cancer	0.000181	0.000482	CcSEcCtD
Fulvestrant—Cough—Doxorubicin—lung cancer	0.000177	0.00047	CcSEcCtD
Fulvestrant—Dizziness—Docetaxel—lung cancer	0.000175	0.000466	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000174	0.000463	CcSEcCtD
Fulvestrant—Insomnia—Methotrexate—lung cancer	0.000172	0.000459	CcSEcCtD
Fulvestrant—Chest pain—Doxorubicin—lung cancer	0.000172	0.000459	CcSEcCtD
Fulvestrant—Arthralgia—Doxorubicin—lung cancer	0.000172	0.000459	CcSEcCtD
Fulvestrant—Myalgia—Doxorubicin—lung cancer	0.000172	0.000459	CcSEcCtD
Fulvestrant—Anxiety—Doxorubicin—lung cancer	0.000172	0.000457	CcSEcCtD
Fulvestrant—Paraesthesia—Methotrexate—lung cancer	0.000171	0.000456	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000171	0.000456	CcSEcCtD
Fulvestrant—Dyspnoea—Methotrexate—lung cancer	0.00017	0.000453	CcSEcCtD
Fulvestrant—Vomiting—Docetaxel—lung cancer	0.000168	0.000448	CcSEcCtD
Fulvestrant—Dyspepsia—Methotrexate—lung cancer	0.000168	0.000447	CcSEcCtD
Fulvestrant—Rash—Docetaxel—lung cancer	0.000167	0.000444	CcSEcCtD
Fulvestrant—Dermatitis—Docetaxel—lung cancer	0.000167	0.000444	CcSEcCtD
Fulvestrant—Decreased appetite—Methotrexate—lung cancer	0.000166	0.000442	CcSEcCtD
Fulvestrant—Headache—Docetaxel—lung cancer	0.000166	0.000442	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Methotrexate—lung cancer	0.000165	0.000439	CcSEcCtD
Fulvestrant—Fatigue—Methotrexate—lung cancer	0.000164	0.000438	CcSEcCtD
Fulvestrant—Infection—Doxorubicin—lung cancer	0.000164	0.000437	CcSEcCtD
Fulvestrant—Pain—Methotrexate—lung cancer	0.000163	0.000434	CcSEcCtD
Fulvestrant—Nervous system disorder—Doxorubicin—lung cancer	0.000162	0.000431	CcSEcCtD
Fulvestrant—Skin disorder—Doxorubicin—lung cancer	0.00016	0.000427	CcSEcCtD
Fulvestrant—Hyperhidrosis—Doxorubicin—lung cancer	0.00016	0.000425	CcSEcCtD
Fulvestrant—Anorexia—Doxorubicin—lung cancer	0.000157	0.000419	CcSEcCtD
Fulvestrant—Nausea—Docetaxel—lung cancer	0.000157	0.000419	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methotrexate—lung cancer	0.000156	0.000415	CcSEcCtD
Fulvestrant—Urticaria—Methotrexate—lung cancer	0.000152	0.000404	CcSEcCtD
Fulvestrant—Abdominal pain—Methotrexate—lung cancer	0.000151	0.000402	CcSEcCtD
Fulvestrant—Body temperature increased—Methotrexate—lung cancer	0.000151	0.000402	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00015	0.000401	CcSEcCtD
Fulvestrant—Insomnia—Doxorubicin—lung cancer	0.000149	0.000398	CcSEcCtD
Fulvestrant—Paraesthesia—Doxorubicin—lung cancer	0.000148	0.000395	CcSEcCtD
Fulvestrant—Dyspnoea—Doxorubicin—lung cancer	0.000147	0.000392	CcSEcCtD
Fulvestrant—Dyspepsia—Doxorubicin—lung cancer	0.000145	0.000387	CcSEcCtD
Fulvestrant—Decreased appetite—Doxorubicin—lung cancer	0.000144	0.000382	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000143	0.00038	CcSEcCtD
Fulvestrant—Fatigue—Doxorubicin—lung cancer	0.000142	0.000379	CcSEcCtD
Fulvestrant—Constipation—Doxorubicin—lung cancer	0.000141	0.000376	CcSEcCtD
Fulvestrant—Pain—Doxorubicin—lung cancer	0.000141	0.000376	CcSEcCtD
Fulvestrant—Hypersensitivity—Methotrexate—lung cancer	0.000141	0.000374	CcSEcCtD
Fulvestrant—Asthenia—Methotrexate—lung cancer	0.000137	0.000364	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Doxorubicin—lung cancer	0.000135	0.00036	CcSEcCtD
Fulvestrant—Pruritus—Methotrexate—lung cancer	0.000135	0.000359	CcSEcCtD
Fulvestrant—Urticaria—Doxorubicin—lung cancer	0.000131	0.000349	CcSEcCtD
Fulvestrant—Body temperature increased—Doxorubicin—lung cancer	0.000131	0.000348	CcSEcCtD
Fulvestrant—Abdominal pain—Doxorubicin—lung cancer	0.000131	0.000348	CcSEcCtD
Fulvestrant—Diarrhoea—Methotrexate—lung cancer	0.00013	0.000348	CcSEcCtD
Fulvestrant—Dizziness—Methotrexate—lung cancer	0.000126	0.000336	CcSEcCtD
Fulvestrant—Hypersensitivity—Doxorubicin—lung cancer	0.000122	0.000324	CcSEcCtD
Fulvestrant—Vomiting—Methotrexate—lung cancer	0.000121	0.000323	CcSEcCtD
Fulvestrant—Rash—Methotrexate—lung cancer	0.00012	0.00032	CcSEcCtD
Fulvestrant—Dermatitis—Methotrexate—lung cancer	0.00012	0.00032	CcSEcCtD
Fulvestrant—Headache—Methotrexate—lung cancer	0.000119	0.000318	CcSEcCtD
Fulvestrant—Asthenia—Doxorubicin—lung cancer	0.000118	0.000316	CcSEcCtD
Fulvestrant—Pruritus—Doxorubicin—lung cancer	0.000117	0.000311	CcSEcCtD
Fulvestrant—Nausea—Methotrexate—lung cancer	0.000113	0.000302	CcSEcCtD
Fulvestrant—Diarrhoea—Doxorubicin—lung cancer	0.000113	0.000301	CcSEcCtD
Fulvestrant—Dizziness—Doxorubicin—lung cancer	0.000109	0.000291	CcSEcCtD
Fulvestrant—Vomiting—Doxorubicin—lung cancer	0.000105	0.00028	CcSEcCtD
Fulvestrant—Rash—Doxorubicin—lung cancer	0.000104	0.000277	CcSEcCtD
Fulvestrant—Dermatitis—Doxorubicin—lung cancer	0.000104	0.000277	CcSEcCtD
Fulvestrant—Headache—Doxorubicin—lung cancer	0.000103	0.000276	CcSEcCtD
Fulvestrant—Nausea—Doxorubicin—lung cancer	9.81e-05	0.000261	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—NQO1—lung cancer	7.56e-05	0.000261	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SKI—lung cancer	7.54e-05	0.000261	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GCLC—lung cancer	7.52e-05	0.00026	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2A6—lung cancer	7.52e-05	0.00026	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP1A1—lung cancer	7.51e-05	0.00026	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ERCC2—lung cancer	7.45e-05	0.000258	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.4e-05	0.000256	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CG—lung cancer	7.36e-05	0.000254	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.33e-05	0.000253	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	7.33e-05	0.000253	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—RAF1—lung cancer	7.21e-05	0.000249	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—NRAS—lung cancer	7.2e-05	0.000249	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	7.16e-05	0.000247	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—CREBBP—lung cancer	7.02e-05	0.000243	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—POMC—lung cancer	7.01e-05	0.000242	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ERCC2—lung cancer	7e-05	0.000242	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	6.97e-05	0.000241	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	6.95e-05	0.00024	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MAPK3—lung cancer	6.9e-05	0.000238	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CREBBP—lung cancer	6.82e-05	0.000236	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—STK11—lung cancer	6.81e-05	0.000235	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MYC—lung cancer	6.74e-05	0.000233	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	6.74e-05	0.000233	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	6.72e-05	0.000232	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—lung cancer	6.59e-05	0.000228	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—lung cancer	6.56e-05	0.000227	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CD—lung cancer	6.47e-05	0.000224	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	6.45e-05	0.000223	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOA1—lung cancer	6.45e-05	0.000223	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	6.41e-05	0.000222	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2E1—lung cancer	6.4e-05	0.000221	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.39e-05	0.000221	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—lung cancer	6.39e-05	0.000221	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MYC—lung cancer	6.32e-05	0.000219	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	6.31e-05	0.000218	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—lung cancer	6.3e-05	0.000218	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.23e-05	0.000216	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—KRAS—lung cancer	6.23e-05	0.000215	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—KRAS—lung cancer	6.2e-05	0.000214	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.17e-05	0.000213	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAT—lung cancer	6.13e-05	0.000212	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—COL4A2—lung cancer	6.11e-05	0.000211	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—ERCC2—lung cancer	6.1e-05	0.000211	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.1e-05	0.000211	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.07e-05	0.00021	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RARB—lung cancer	6.06e-05	0.000209	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCB1—lung cancer	5.97e-05	0.000206	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GIPR—lung cancer	5.95e-05	0.000206	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NPPA—lung cancer	5.9e-05	0.000204	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CG—lung cancer	5.88e-05	0.000203	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TYMS—lung cancer	5.86e-05	0.000203	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—lung cancer	5.79e-05	0.0002	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	5.74e-05	0.000199	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CA—lung cancer	5.69e-05	0.000197	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CB—lung cancer	5.64e-05	0.000195	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—lung cancer	5.6e-05	0.000194	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—lung cancer	5.59e-05	0.000193	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	5.59e-05	0.000193	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SDC4—lung cancer	5.56e-05	0.000192	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—lung cancer	5.54e-05	0.000191	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MYC—lung cancer	5.5e-05	0.00019	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP1A1—lung cancer	5.49e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.46e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CREBBP—lung cancer	5.46e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DUSP3—lung cancer	5.45e-05	0.000188	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ERCC2—lung cancer	5.44e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RHEB—lung cancer	5.34e-05	0.000185	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—lung cancer	5.27e-05	0.000182	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—HRAS—lung cancer	5.27e-05	0.000182	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	5.2e-05	0.00018	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CD—lung cancer	5.17e-05	0.000179	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.16e-05	0.000178	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—CREBBP—lung cancer	5.13e-05	0.000177	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—lung cancer	5.11e-05	0.000177	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPB1—lung cancer	5.08e-05	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM8—lung cancer	5.06e-05	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—lung cancer	5.04e-05	0.000174	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SKI—lung cancer	4.9e-05	0.00017	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTEN—lung cancer	4.87e-05	0.000169	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.85e-05	0.000168	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.78e-05	0.000165	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.74e-05	0.000164	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOA1—lung cancer	4.71e-05	0.000163	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—CREBBP—lung cancer	4.68e-05	0.000162	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—lung cancer	4.68e-05	0.000162	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—lung cancer	4.65e-05	0.000161	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—EP300—lung cancer	4.65e-05	0.000161	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.59e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.59e-05	0.000159	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.53e-05	0.000157	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.51e-05	0.000156	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CB—lung cancer	4.51e-05	0.000156	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH3—lung cancer	4.47e-05	0.000155	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—lung cancer	4.47e-05	0.000154	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—CREBBP—lung cancer	4.46e-05	0.000154	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CG—lung cancer	4.3e-05	0.000149	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MAPK3—lung cancer	4.28e-05	0.000148	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PXN—lung cancer	4.26e-05	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—JUNB—lung cancer	4.24e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKR1C1—lung cancer	4.17e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OXTR—lung cancer	4.17e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRP—lung cancer	4.17e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—lung cancer	4.16e-05	0.000144	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—lung cancer	4.09e-05	0.000142	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.04e-05	0.00014	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AZIN2—lung cancer	4.04e-05	0.00014	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CREBBP—lung cancer	3.99e-05	0.000138	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNG11—lung cancer	3.9e-05	0.000135	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTEN—lung cancer	3.9e-05	0.000135	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.87e-05	0.000134	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CD—lung cancer	3.78e-05	0.000131	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—lung cancer	3.73e-05	0.000129	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFC—lung cancer	3.72e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—EP300—lung cancer	3.72e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADCY1—lung cancer	3.51e-05	0.000121	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—lung cancer	3.44e-05	0.000119	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ATP5H—lung cancer	3.44e-05	0.000119	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—lung cancer	3.43e-05	0.000118	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SMARCA4—lung cancer	3.42e-05	0.000118	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP2R1B—lung cancer	3.42e-05	0.000118	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HSPB1—lung cancer	3.3e-05	0.000114	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CB—lung cancer	3.29e-05	0.000114	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—lung cancer	3.26e-05	0.000113	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTHLH—lung cancer	3.26e-05	0.000113	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MAPK3—lung cancer	3.13e-05	0.000108	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ERCC2—lung cancer	3.07e-05	0.000106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ANXA1—lung cancer	3.07e-05	0.000106	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLBD1—lung cancer	3.06e-05	0.000106	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—lung cancer	3.04e-05	0.000105	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FLT1—lung cancer	2.97e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH3—lung cancer	2.91e-05	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APP—lung cancer	2.91e-05	0.000101	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—lung cancer	2.89e-05	9.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF9—lung cancer	2.88e-05	9.97e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTEN—lung cancer	2.85e-05	9.84e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—lung cancer	2.81e-05	9.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD17B10—lung cancer	2.8e-05	9.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—lung cancer	2.78e-05	9.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUNB—lung cancer	2.75e-05	9.52e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—lung cancer	2.75e-05	9.5e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MAPK3—lung cancer	2.72e-05	9.42e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—EP300—lung cancer	2.72e-05	9.39e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—lung cancer	2.65e-05	9.16e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CKB—lung cancer	2.6e-05	9.01e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STK11—lung cancer	2.5e-05	8.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM2—lung cancer	2.45e-05	8.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CNDP2—lung cancer	2.45e-05	8.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FOXO3—lung cancer	2.41e-05	8.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTMR3—lung cancer	2.38e-05	8.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PGAM1—lung cancer	2.32e-05	8.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AVP—lung cancer	2.26e-05	7.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CREBBP—lung cancer	2.25e-05	7.78e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—lung cancer	2.25e-05	7.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2A7—lung cancer	2.21e-05	7.66e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1R—lung cancer	2.18e-05	7.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SDC4—lung cancer	2.17e-05	7.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HES1—lung cancer	2.14e-05	7.39e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—lung cancer	2.11e-05	7.3e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—lung cancer	2.01e-05	6.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTA3—lung cancer	1.97e-05	6.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RRM1—lung cancer	1.97e-05	6.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB3—lung cancer	1.96e-05	6.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TERT—lung cancer	1.87e-05	6.48e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—B4GALT5—lung cancer	1.86e-05	6.42e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—lung cancer	1.84e-05	6.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGFR1—lung cancer	1.82e-05	6.29e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTA4—lung cancer	1.81e-05	6.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIF1A—lung cancer	1.79e-05	6.2e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTA2—lung cancer	1.76e-05	6.08e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA1—lung cancer	1.73e-05	5.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—lung cancer	1.71e-05	5.93e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTA1—lung cancer	1.7e-05	5.87e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCC3—lung cancer	1.68e-05	5.8e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—lung cancer	1.64e-05	5.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1C1—lung cancer	1.63e-05	5.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APC—lung cancer	1.58e-05	5.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KIT—lung cancer	1.58e-05	5.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CG—lung cancer	1.58e-05	5.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UGT1A1—lung cancer	1.58e-05	5.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGF—lung cancer	1.56e-05	5.4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GNG11—lung cancer	1.52e-05	5.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—lung cancer	1.5e-05	5.2e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BRAF—lung cancer	1.48e-05	5.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6R—lung cancer	1.47e-05	5.07e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CREBBP—lung cancer	1.46e-05	5.06e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDOA—lung cancer	1.45e-05	5.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NCOA3—lung cancer	1.41e-05	4.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAP2K1—lung cancer	1.4e-05	4.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CD—lung cancer	1.39e-05	4.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MAPK3—lung cancer	1.37e-05	4.75e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCG2—lung cancer	1.37e-05	4.73e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADCY1—lung cancer	1.37e-05	4.73e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENO2—lung cancer	1.34e-05	4.64e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HPGDS—lung cancer	1.34e-05	4.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—lung cancer	1.34e-05	4.62e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.33e-05	4.61e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—lung cancer	1.3e-05	4.5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2A6—lung cancer	1.29e-05	4.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCLC—lung cancer	1.29e-05	4.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MDM2—lung cancer	1.24e-05	4.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RAF1—lung cancer	1.24e-05	4.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB2—lung cancer	1.23e-05	4.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENO1—lung cancer	1.22e-05	4.22e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MTOR—lung cancer	1.21e-05	4.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CB—lung cancer	1.21e-05	4.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—lung cancer	1.16e-05	4.02e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—lung cancer	1.11e-05	3.85e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—lung cancer	1.11e-05	3.84e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2E1—lung cancer	1.09e-05	3.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCND1—lung cancer	1.08e-05	3.75e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NQO1—lung cancer	1.08e-05	3.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUN—lung cancer	1.08e-05	3.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—lung cancer	1.05e-05	3.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1A—lung cancer	1.05e-05	3.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTEN—lung cancer	1.05e-05	3.61e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EP300—lung cancer	9.97e-06	3.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STK11—lung cancer	9.75e-06	3.37e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SRC—lung cancer	9.69e-06	3.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—lung cancer	9.44e-06	3.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—lung cancer	9.35e-06	3.23e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NRAS—lung cancer	9.33e-06	3.22e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—lung cancer	9.27e-06	3.2e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—lung cancer	9.02e-06	3.12e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK3—lung cancer	8.93e-06	3.09e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAT—lung cancer	8.78e-06	3.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—lung cancer	8.69e-06	3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCB1—lung cancer	8.54e-06	2.95e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—lung cancer	8.5e-06	2.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TYMS—lung cancer	8.39e-06	2.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—lung cancer	8.29e-06	2.87e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KRAS—lung cancer	8.03e-06	2.78e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP1A1—lung cancer	7.86e-06	2.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ERCC2—lung cancer	7.79e-06	2.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—lung cancer	7.38e-06	2.55e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—lung cancer	7.13e-06	2.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRAS—lung cancer	6.82e-06	2.36e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA1—lung cancer	6.74e-06	2.33e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—lung cancer	6.53e-06	2.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CG—lung cancer	6.16e-06	2.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—lung cancer	6.02e-06	2.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—lung cancer	5.86e-06	2.03e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CREBBP—lung cancer	5.71e-06	1.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CD—lung cancer	5.41e-06	1.87e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—lung cancer	5.34e-06	1.85e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CB—lung cancer	4.72e-06	1.63e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—lung cancer	4.67e-06	1.62e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTEN—lung cancer	4.08e-06	1.41e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—EP300—lung cancer	3.89e-06	1.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—lung cancer	2.88e-06	9.94e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—lung cancer	2.35e-06	8.12e-06	CbGpPWpGaD
